|
|
Office Locations:
|
1270 Coast Village Circle, Suite 100
Santa Barbara, CA 93108
Phone: 805-684-6515
Fax: 805-684-6511
| | |
|
|
|
- Early
- Expansion
- Growth
- Seed
|
|
|
|
Energy & Clean Tech
Life Sciences & Healthcare
Medical Device
|
|
|
|
Cycad Group is a venture capital firm focusing on investments in companies with enabling solutions, disruptive technologies and innovative products. Cycad Group is opportunistic and doesn't limit its investment activities to any single industry sector. However, the firm actively pursues investment opportunities in the areas of (i) energy technologies; (ii) advanced materials and chemical processes; and (iii) life sciences (e.g., biotechnology, pharmaceuticals, medical devices and analytical tools). Cycad has experience investing in companies at all stages of development, from the first round of outside financing to PIPE transactions. Cycad Group searches for investments in companies with revenue potential exceeding $100 million and an identified exit strategy/liquidity event.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
